These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8381487)

  • 21. Effects of chronic oral administration of L-deprenyl in the dog.
    Milgram NW; Ivy GO; Murphy MP; Head E; Wu PH; Ruehl WW; Yu PH; Durden DA; Davis BA; Boulton AA
    Pharmacol Biochem Behav; 1995; 51(2-3):421-8. PubMed ID: 7667363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid development of brain beta-adrenoceptor down-regulation induced by phenelzine: subcellular studies.
    Koshikawa N; Maruyama Y; Kobayashi M; Campbell IC
    Eur J Pharmacol; 1989 Oct; 170(1-2):101-4. PubMed ID: 2558891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of beta-phenylethylamine from the antidepressant, beta-phenylethylhydrazine.
    Dyck LE; Durden DA; Boulton AA
    Biochem Pharmacol; 1985 Jun; 34(11):1925-9. PubMed ID: 4004908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
    Ordway GA; Gambarana C; Tejani-Butt SM; Areso P; Hauptmann M; Frazer A
    J Pharmacol Exp Ther; 1991 May; 257(2):681-90. PubMed ID: 1674532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo relationship between monoamine oxidase type B and alcohol dehydrogenase: effects of ethanol and phenylethylamine.
    Aliyu SU; Upahi L
    Life Sci; 1988; 43(4):345-56. PubMed ID: 3398704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing the response of the cerebral circulation to phenylethylamine.
    McCulloch J; Harper AM
    Neurology; 1979 Feb; 29(2):201-7. PubMed ID: 219389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-adrenergic effects on plasma and brain large neutral amino acids are unaltered by chronic administration of antidepressants.
    Paetsch PR; Greenshaw AJ
    J Neurochem; 1991 Jun; 56(6):2027-32. PubMed ID: 1673998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors.
    Bergman J; Yasar S; Winger G
    Psychopharmacology (Berl); 2001 Dec; 159(1):21-30. PubMed ID: 11797065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desynchronization of electrical activity in rats induced by deprenyl--an inhibitor of monoamine oxidase B--and relationship with selective increase of dopamine and beta-phenylethylamine.
    Dzoljic MR; Bruinvels J; Bonta IL
    J Neural Transm; 1977; 40(1):1-12. PubMed ID: 833580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of antidepressants on GABAB and beta-adrenergic receptors in rat cerebral cortex.
    McManus DJ; Greenshaw AJ
    Biochem Pharmacol; 1991 Sep; 42(8):1525-8. PubMed ID: 1656988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of monoamines from striatal slices by phenelzine and beta-phenylethylamine.
    Dyck LE
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):797-800. PubMed ID: 6686711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
    Braestrup C; Andersen H; Randrup A
    Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural response to SKF 38393 and quinpirole following chronic antidepressant treatment.
    Allison K; Ivanová S; Greenshaw AJ
    Eur J Pharmacol; 1995 Apr; 277(2-3):139-44. PubMed ID: 7493601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amine oxidase released into plasma of rats treated with hepatotoxin allyl formate.
    Obata T; Egashira T; Yamanaka Y
    Res Commun Chem Pathol Pharmacol; 1989 Oct; 66(1):69-85. PubMed ID: 2515565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A; Glover V; Oxenkrug GF; Sandler M
    Neurosci Lett; 1989 Dec; 107(1-3):331-4. PubMed ID: 2616044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of 2-phenylethylamine binding after monoamine oxidase inhibition in rat brain.
    Li XM; Juorio AV; Paterson IA; Boulton AA
    Eur J Pharmacol; 1992 Jan; 210(2):189-93. PubMed ID: 1601056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V; Pycock CJ; Sandler M
    Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.